EUVIMEDEUVIMED entdecken
Crossref

NEK2 Promotes ESCC Malignant Progression by Inhibiting Cellular Senescence via the FOXM1/c‐Myc/p27 Signaling Pathway

Jiachen Li iD, Yaojie Wang, Sisi Wei, Shi Xu, Suli Dai, Li Zhang, Ziqiang Tian, Lianmei Zhao iD, Huilai Lv

Molecular Carcinogenesis · 2025

DOI: 10.1002/mc.23839 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2025. Verfasst von Jiachen Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China. Hauptthemen laut MEDLINE: NIMA-Related Kinases, Forkhead Box Protein M1, Cellular Senescence, Esophageal Squamous Cell Carcinoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: This study was supported by Hebei Provincial Natural Science Foundation (H2022206443)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Never in mitosis gene A (NIMA)‐related kinase 2 (NEK2) is a crucial serine‐threonine kinase involved in the process of cell mitosis. However, the precise relationship between NEK2 and esophageal squamous cell carcinoma (ESCC) remains inadequately understood. NEK2 expression in ESCC tissues was assessed through bioinformatics analysis, reverse transcription‐quantitative PCR (RT‐qPCR) and immunohistochemistry, revealing a correlation with ESCC patient prognosis. Cultured ESCC cells and human normal esophageal epithelial cells (HEEC) were used to investigate the effects of NEK2 knockdown on the development and progression of ESCC by integrated confluence algorithm, colony formation, wound‐healing, transwell, and ESCC xenograft tumor model, in vitro and in vivo. In ESCC tissues, NEK2 was found to be significantly upregulated, and its expression correlated with poor prognosis in ESCC patients. NEK2 may facilitate ESCC development by regulating cell proliferation, migration, and invasion. Additionally, results from in vivo experiments suggested that NEK2 knockdown can inhibit tumor growth. Moreover, forkhead box M1 (FOXM1) was identified as a potential downstream target of NEK2 in the regulation of ESCC, with its overexpression reversing the effects of NEK2 knockdown on ESCC. Mechanistic studies also indicated that NEK2 may promote the malignant progression of ESCC by inhibiting cellular senescence through the activation of the FOXM1/c‐Myc/p27 signaling pathways, which may provide a novel perspective for the management of ESCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NIMA-Related KinasesForkhead Box Protein M1Cellular SenescenceEsophageal Squamous Cell CarcinomaEsophageal NeoplasmsProto-Oncogene Proteins c-mycHumansAnimalsMiceCell ProliferationSignal TransductionFemaleMalePrognosisGene Expression Regulation, NeoplasticDisease ProgressionMiddle AgedCell MovementCell Line, TumorMice, NudeXenograft Model Antitumor AssaysMice, Inbred BALB CBiomarkers, TumorCyclin-Dependent Kinase Inhibitor p27

Stichwörter der Autor:innen

ESCCFOXM1NEK2cellular senescenceproliferation

Substanzen

NIMA-Related KinasesForkhead Box Protein M1FOXM1 protein, humanNEK2 protein, humanProto-Oncogene Proteins c-mycMYC protein, humanCDKN1B protein, humanBiomarkers, TumorCyclin-Dependent Kinase Inhibitor p27

Autor:innen und Institutionen

  • Department of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
  • Research Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
  • Key Laboratory of Tumor Gene Diagnosis, Prevention, and Therapy of Hebei Province, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
  • Department of Geriatric, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.

ORCID-Profile: Jiachen Li, Lianmei Zhao

Förderung

  • This study was supported by Hebei Provincial Natural Science Foundation (H2022206443).

Zitieren

APA

Li, J., Wang, Y., Wei, S., Xu, S., Dai, S., Zhang, L., Tian, Z., Zhao, L., & Lv, H. (2025). NEK2 Promotes ESCC Malignant Progression by Inhibiting Cellular Senescence via the FOXM1/c‐Myc/p27 Signaling Pathway. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23839

Vancouver

Li J, Wang Y, Wei S, Xu S, Dai S, Zhang L, et al. NEK2 Promotes ESCC Malignant Progression by Inhibiting Cellular Senescence via the FOXM1/c‐Myc/p27 Signaling Pathway. Molecular Carcinogenesis. 2025. doi:10.1002/mc.23839

BibTeX
@article{Li2025,
  author = {Li, Jiachen and Wang, Yaojie and Wei, Sisi and Xu, Shi and Dai, Suli and Zhang, Li and Tian, Ziqiang and Zhao, Lianmei and Lv, Huilai},
  title = {NEK2 Promotes ESCC Malignant Progression by Inhibiting Cellular Senescence via the FOXM1/c‐Myc/p27 Signaling Pathway},
  journal = {Molecular Carcinogenesis},
  year = {2025},
  doi = {10.1002/mc.23839}
}
Kostenlos starten →